Analysis Article • Jul 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedJul 16, 2026
DataAggregated Company Financials
Companies6
- 7D-0.9%
- 3M-27.6%
- 1Y-23.2%
- YTDn/a
Last week, the Drug Retail industry hasn't moved much but JD Health International is up 7.4% in that time. As for the longer term, the industry has declined 23% in the last year. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 17 Jul 2026 | HK$193.2b | HK$143.1b | HK$8.7b | 30.2x | 22.2x | 1.4x |
| Sun, 14 Jun 2026 | HK$199.3b | HK$143.3b | HK$8.7b | 33.8x | 22.8x | 1.4x |
| Tue, 12 May 2026 | HK$250.3b | HK$141.0b | HK$8.7b | 43.7x | 28.9x | 1.8x |
| Thu, 09 Apr 2026 | HK$277.2b | HK$140.4b | HK$8.6b | 48.1x | 32.1x | 2x |
| Sat, 07 Mar 2026 | HK$269.8b | HK$139.1b | HK$7.7b | 37.9x | 35.1x | 1.9x |
| Mon, 02 Feb 2026 | HK$346.5b | HK$128.5b | HK$6.9b | 48.6x | 50.3x | 2.7x |
| Wed, 31 Dec 2025 | HK$301.2b | HK$127.3b | HK$6.8b | 38.4x | 44.2x | 2.4x |
| Fri, 28 Nov 2025 | HK$331.3b | HK$125.6b | HK$6.7b | 43.9x | 49.3x | 2.6x |
| Sun, 26 Oct 2025 | HK$335.6b | HK$122.1b | HK$6.1b | 61x | 54.7x | 2.7x |
| Tue, 23 Sep 2025 | HK$375.7b | HK$122.3b | HK$6.1b | 67.5x | 61.1x | 3.1x |
| Thu, 21 Aug 2025 | HK$334.1b | HK$121.7b | HK$5.2b | 55.2x | 64.4x | 2.7x |
| Sat, 19 Jul 2025 | HK$260.1b | HK$115.4b | HK$4.5b | 48.4x | 57.7x | 2.3x |
| Mon, 16 Jun 2025 | HK$230.0b | HK$115.3b | HK$4.5b | 47.3x | 51.1x | 2x |
| Wed, 14 May 2025 | HK$230.3b | HK$111.8b | HK$4.2b | 63.7x | 54.6x | 2.1x |
| Fri, 11 Apr 2025 | HK$198.6b | HK$109.3b | HK$4.1b | 55.8x | 48.2x | 1.8x |
| Sun, 09 Mar 2025 | HK$225.2b | HK$108.0b | HK$5.3b | 47.1x | 42.7x | 2.1x |
| Tue, 04 Feb 2025 | HK$170.2b | HK$104.5b | HK$3.6b | 38.9x | 47.1x | 1.6x |
| Thu, 02 Jan 2025 | HK$155.0b | HK$103.4b | HK$3.6b | 36.9x | 43.3x | 1.5x |
| Sat, 30 Nov 2024 | HK$170.7b | HK$104.4b | HK$3.6b | 38.7x | 47.2x | 1.6x |
| Mon, 28 Oct 2024 | HK$173.9b | HK$104.6b | HK$3.3b | 49x | 52.4x | 1.7x |
| Wed, 25 Sep 2024 | HK$155.8b | HK$106.1b | HK$3.4b | 42.3x | 46.3x | 1.5x |
| Fri, 23 Aug 2024 | HK$134.9b | HK$104.7b | HK$3.3b | 37.5x | 40.6x | 1.3x |
| Sun, 21 Jul 2024 | HK$136.9b | HK$101.8b | HK$2.4b | 42.2x | 57.4x | 1.3x |
| Tue, 18 Jun 2024 | HK$153.0b | HK$102.0b | HK$2.4b | 46.2x | 64x | 1.5x |
| Thu, 16 May 2024 | HK$169.0b | HK$103.8b | HK$2.3b | 49.9x | 72.6x | 1.6x |
| Sat, 13 Apr 2024 | HK$139.7b | HK$103.9b | HK$2.3b | 41.8x | 59.9x | 1.3x |
| Mon, 11 Mar 2024 | HK$162.1b | HK$105.2b | -HK$1,457,577,057.48 | 53.7x | -111.2x | 1.5x |
| Wed, 07 Feb 2024 | HK$158.8b | HK$106.4b | -HK$1,473,953,513.27 | 51x | -107.7x | 1.5x |
| Fri, 05 Jan 2024 | HK$192.5b | HK$105.5b | -HK$1,462,446,819.00 | 59.8x | -131.7x | 1.8x |
| Sun, 03 Dec 2023 | HK$202.1b | HK$105.8b | -HK$1,466,070,775.00 | 63.8x | -137.9x | 1.9x |
| Tue, 31 Oct 2023 | HK$207.0b | HK$101.8b | -HK$1,734,918,252.00 | 86.6x | -119.3x | 2x |
| Thu, 28 Sep 2023 | HK$221.7b | HK$102.2b | -HK$1,673,053,191.00 | 101.6x | -132.5x | 2.2x |
| Sat, 26 Aug 2023 | HK$233.4b | HK$101.9b | -HK$2,455,510,551.00 | 75x | -95x | 2.3x |
| Mon, 24 Jul 2023 | HK$270.4b | HK$96.2b | -HK$4,174,629,592.00 | 117.7x | -64.8x | 2.8x |
Price to Earnings Ratio
-64.8x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 22.2x which is lower than its 3-year average PE of 98.3x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 0.62% | |
| Consumer Staples | 1.65% | |
| Food and Staples Retail | 1.64% | |
| Drug Retail | -0.93% | |
| Food Retail | 5.89% | |
| Big Box Super Stores | 4.30% | |
| Food Distributors | -3.03% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$39.20 | 7.4% +HK$8.6b | -16.3% | PE20.1x | |
| 241 Alibaba Health Information Technology | HK$3.47 | 2.1% +HK$1.1b | -25.2% | PE25x | |
| 1833 Ping An Healthcare and Technology | HK$7.79 | 5.6% +HK$871.9m | -20.3% | PE37.7x | |
| 6086 Fangzhou | HK$0.85 | 18.1% +HK$180.1m | -78.0% | PE85.9x | |
| 2290 Lung Fung Group Holdings | HK$3.57 | 3.2% +HK$55.0m | n/a | PE10.5x |